Circio Holding ASA: First half 2024 results
Oslo, Norway, 29 August 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA gene therapies, today announces its first half-year 2024 results. Circio’s management will present the results in a live-streamed webcast at 10:00 am CEST to investors, analysts and the press. Click here for access to the live webcast